Antibiotic News and Research RSS Feed - Antibiotic News and Research

Antibiotics are drugs used to treat infections caused by bacteria and other microorganisms.
Grifols signs worldwide licensing agreement for Aradigm's Pulmaquin

Grifols signs worldwide licensing agreement for Aradigm's Pulmaquin

Grifols, S.A. and Aradigm Corporation today announced the signing of an exclusive, worldwide license for Aradigm's proprietary formulations of inhaled ciprofloxacin (Pulmaquin and Lipoquin) for the treatment of severe respiratory diseases, including non-cystic fibrosis bronchiectasis. [More]
Patient compliance: an interview with Dr. Bassam Damaj, CEO of Innovus Pharma

Patient compliance: an interview with Dr. Bassam Damaj, CEO of Innovus Pharma

A medication’s optimal results are achieved with specific dose levels and times of administration. In order for patients to achieve the maximum benefit from a medication, they have to adhere to the prescribed dose and time of use. [More]
Certain varieties of clay have ability to kill MRSA, says ASU researcher

Certain varieties of clay have ability to kill MRSA, says ASU researcher

In the race to protect society from infectious microbes, the bugs are outrunning us. The need for new therapeutic agents is acute, given the emergence of novel pathogens as well as old foes bearing heightened antibiotic resistance. [More]
Sorrento Therapeutics' anti-MRSA program gets NIAID support

Sorrento Therapeutics' anti-MRSA program gets NIAID support

Sorrento Therapeutics, Inc. announced today that its Fast-Track Advanced Technology Small Business Technology Transfer Research grant (#1R42AI098182-02) from the National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health, supporting the development of novel human antibody therapeutics to combat Staphylococcus aureus (S. aureus or Staph) infections, including methicillin-resistant S. aureus, was renewed for the second year of a two year Phase I grant award. [More]
Thioridazine works by weakening staphylococcal cell wall, new study reveals

Thioridazine works by weakening staphylococcal cell wall, new study reveals

In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as staphylococci (Staphylococcus aureus). [More]
Ambulatory syringe pump training: an interview with Ruth Goodwin RGN, BSc Clinical Education Manager for CME Medical

Ambulatory syringe pump training: an interview with Ruth Goodwin RGN, BSc Clinical Education Manager for CME Medical

Ambulatory pumps allow patients to continue receiving treatment or therapy away from a hospital, thereby leading a normal life during treatment. Due to the size and design of these pumps, patients can carry them around in a carry pouch. [More]
Stanford engineers develop new type of nanoscavenger for water purification

Stanford engineers develop new type of nanoscavenger for water purification

Among its many talents, silver is an antibiotic. Titanium dioxide is known to glom on to certain heavy metals and pollutants. Yet other materials do the same for salt. In recent years, environmental engineers have sought to disinfect, depollute, and desalinate contaminated water using nanoscale particles of these active materials. Engineers call them nanoscavengers. The hitch from a technical standpoint is that it is nearly impossible to reclaim the nanoscavengers once in the water. [More]
Antibiotic stewardship program using MALDI Biotyper reduces hospital stays, overall costs

Antibiotic stewardship program using MALDI Biotyper reduces hospital stays, overall costs

A co-author of a groundbreaking study documenting reductions in patient length of stay and overall costs from implementation of an antibiotic stewardship program using Bruker's MALDI Biotyper will share her observations at a Bruker symposium to be held during the upcoming American Society for Microbiology General Meeting. [More]
IFR scientists mine the genome of C. botulinum to reveal new information about toxin genes

IFR scientists mine the genome of C. botulinum to reveal new information about toxin genes

The toxin that causes botulism is the most potent that we know of. Eating an amount of toxin just 1000th the weight of a grain of salt can be fatal, which is why so much effort has been put into keeping Clostridium botulinum, which produces the toxin, out of our food. [More]

Discovery provides vital clues for new antibiotics against MRSA

Scientists at Imperial College London have identified four new proteins that act as receptors for an essential signalling molecule in bacteria such as MRSA. [More]
COPD patients with allergic phenotype have increased risk of lower respiratory symptoms, exacerbations

COPD patients with allergic phenotype have increased risk of lower respiratory symptoms, exacerbations

Patients with chronic obstructive pulmonary disease (COPD) who also have allergic disease have higher levels of respiratory symptoms and are at higher risk for COPD exacerbations, according to a new study from researchers at Johns Hopkins University in Baltimore. [More]

Study identifies national variations in using antibiotics to treat ARS

Antibiotics for acute rhinosinusitis are prescribed frequently- especially for younger adult patients and in primary care settings-despite recent consensus guidelines that discourage antibiotic use in mild cases, according to a study in the May 2013 issue of Otolaryngology-Head and Neck Surgery. [More]

Research could help battle stubborn bacterial infections that do not respond to antibiotics

Bacteria on a surface wander around and often organize into highly resilient communities known as biofilms. It turns out that they organize in a rich-get-richer pattern similar to many economies, according to a new study by researchers at UCLA, Northwestern University and the University of Washington. [More]

Scientists use phages to prevent bacteria on medical devices

They're ba-ack! But in a new disease-fighting role. Viruses that infect and kill bacteria - used to treat infections in the pre-antibiotic era a century ago and in the former Soviet Union today - may have a new role in preventing formation of the sticky "biofilms" of bacteria responsible for infections on implanted medical devices. [More]
New biosensor detects antibiotic resistance in bacteria, can help fight superbugs

New biosensor detects antibiotic resistance in bacteria, can help fight superbugs

On May 8th JoVE will publish research that demonstrates how a biosensor can detect antibiotic resistance in bacteria. This new technology is a preliminary step in identifying and fighting superbugs, a major public health concern that has led to more deaths than AIDS in the United States in recent years. [More]
Genetic loci associated with H pylori bacteria are linked to stomach cancer

Genetic loci associated with H pylori bacteria are linked to stomach cancer

Two genome-wide association studies and a subsequent meta-analysis have found that certain genetic variations are associated with susceptibility to Helicobacter pylori, a bacteria that is a major cause of gastritis and stomach ulcers and is linked to stomach cancer, findings that may help explain some of the observed variation in individual risk for H pylori infection, according to a study in the May 8 issue of JAMA. [More]
Researchers discover potential treatment for deadly, drug-resistant bacterial infections

Researchers discover potential treatment for deadly, drug-resistant bacterial infections

Through the serendipity of science, researchers at the University of Pittsburgh have discovered a potential treatment for deadly, drug-resistant bacterial infections that uses the same approach that HIV uses to infect cells. [More]
Cubist receives Fast Track designation from FDA for late-stage antibiotic candidate

Cubist receives Fast Track designation from FDA for late-stage antibiotic candidate

Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted the Company's late-stage antibiotic candidate ceftolozane/tazobactam (CXA-201) Fast Track status in the previously granted Qualified Infectious Disease Product indications, Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia and Complicated Urinary Tract Infections. [More]

Royal Society elects scientists from JIC for advances in antibiotic discovery and in crop improvement

Two scientists from the John Innes Centre have been elected as Fellows of the Royal Society, the premier scientific accolade in the UK. Their breakthroughs in fundamental research have pioneered advances in antibiotic discovery and in crop improvement from which we all benefit. [More]
New technology can help save millions of infant lives

New technology can help save millions of infant lives

Thanks to new federal funding, low-cost, easily accessible technology invented by a Simon Fraser University engineering professor and his graduate students is closer to helping to save millions of infant lives. [More]